For Verily, a life health company owned by Google's parent company, Alphabet, it can be said that it is a happy event. On January 3, verily just got $1 billion in financing, and on the 18th it spent $40 million to acquire Fossil's smartwatch business; just yesterday (January 20th), verily's smart watch's ECG monitoring function was acquired again. FDA certification. This means that in the field of medical-grade wearable devices, not only Apple alone, Google joined the battle, there are two giants stand.
2015, Google reorganized into Alphabet, Verily company is carrying most of the Alphabet's health care business. The subsidiary focuses on using data to improve healthcare through analytical tools, interventions, research, and more. In the article, Google will replace Alphabet for everyone to read.
From Google's series of actions, we can see that the technology giant is no longer testing the water in the field of medical health, but has begun to fight in large arms. At the same time, Apple, Google, Microsoft, Amazon and other technology giants have also joined forces with traditional players to compete with their opponents.
Google and Apple start to meet each other
Although verily's study watch is currently used primarily in clinical trials, FDA-approved ECG monitoring means that researchers can use the data directly, and the study watch is currently classified as a Class II medical device. However, Google is likely to apply verily's technology to Pixel Watch, the front bar Apple Watch.
Because just last week, Google just bought Fossil's smartwatch technology for $40 million, and Google's acquisition may be just to catch up with Apple.
In the past, the major technology giants have nothing to do with health care. Google is the mainstay of AI in the medical and health field, and Apple is a relatively scattered layout. Amazon bought the pillpack for $1 billion last year and entered the medical and health field. . Amazon's entry into the traditional pharmacy retail CVS, Wal-Mart shares fell.
In the past, everyone's investment in the medical and health field can still be seen as an attempt, but now with the product's landing, positive competition is unavoidable. For example, now Apple and Google are one of the few technology giants to receive FDA-approved ECG monitoring. They also have a large number of users and data, and they also truly cross the threshold of medical-grade products. Separate.
In the article that the arterial network analyzed Apple's strategy yesterday, it can be seen that Apple is mainly committed to building medical services HealthKit, CareKit and ResearchKit in medical health. ResearchKit is built for clinical trial data collection.
In this field, it is also the area where Google focuses on photography. Google’s FDA-approved Study Watch was also built for clinical trials. It can help researchers better monitor participants' vital signs and provide more data. Verily's back-end algorithms and machine learning tools can also process this data on the cloud.
Judging from the current results, the giant pharmaceutical company Gilead invested 90 million US dollars in 2018 to cooperate with Verily. In the past, such a large amount of data was simply inoperable and imaginable, but now with the blessing of verily computing technology, it all is different.
Gilead's chief scientist John McHutchison also bluntly stated that Gilead had been watching Verily's technology for some time before working together. It can be said that Verily's platform has received some recognition.
Google's study Watch
Verily stationed Walgreens to fight against Amazon
Last year, when Amazon announced a $1 billion acquisition of online pharmacy pillpack, the market value of traditional US pharmacy retail giants such as Walgreens, CVS and Rite Aid evaporated by about $14.5 billion. A simple acquisition has plunged the traditional pharmacy giants, showing the strength of technology giants such as Amazon.
Amazon's over 300 million users, the economies of scale, have eroded many traditional industries, and pharmacy retail is likely to be the next.
While traditional pharmacies need more ally to fight against risks, they can't rely on their own efforts. After all, Walgreens' market value is less than 10% of Amazon's. Walgreens then cooperated with technology giants such as Verily and Microsoft to form an alliance.
According to a report by Business Insider, Verily teamed up with Walgreens to provide Walgreens with a number of services.
The main content of cooperation is in the management of diabetes. First verily will provide Walgreens with a “virtual diabetes program†based on the diabetes-based virtual clinic Onduo. In this regard, Google's verily is still very emboldened and capitalized.
As early as 2016, verily and the pharmaceutical giant Sanofi jointly invested $500 million to establish Onduo, an online type 2 diabetes management platform. After registering Onduo, users can receive a set of delivery monitoring equipment for free; then they will get exclusive diabetes management coach on the APP; finally Onduo will use technology products to monitor the user's health information at any time and be professionally provided by a professional medical team. Health management advice.
In addition, verily can also sell in Walgreens after developing the product.
The cooperation between Walgreens and Microsoft is more biased towards the B-end. Walgreens and Microsoft formed an alliance to jointly enter the US pharmaceutical market worth $814.7 billion. They will work together on cloud computing to connect big data with medicine. As we all know, Microsoft and Amazon are the giants of global cloud computing. At present, the world's cloud computing market share is the first Amazon, and Microsoft ranks second.
It is worth mentioning that Amazon's AWS also released Comprehend Medical software, enough to smell the smell of gunpowder.
In the future, we may also see more cooperation between Google and traditional pharmacy retail giants. For example, in the insurance sector, Google's parent company Alphabet has invested in Oscar Health for $375 million. Walgreens' rival CVS acquired the health insurance company Aetna (Aetna) for $70 billion in insurance.
Oscar Health has made multiple investments in Google's Alphabet, GV, Verily Life Sciences and CapitalG, saying that he is not a relative of Google's daughter. In the future, it is very possible to cooperate with many of Google's partners, and there are already precedents for this.
For example, the CGM monitoring used in Onduo is the Dexcom CGM used. Dexcom Dekang was also a partner of Google's verily. The two companies have collaborated on the development of a small continuous glucose monitor (CGM), hoping to create a smaller disposable sensor that can be worn like a bandage for 14 days without the need for finger blood needle calibration (as opposed to the current G6, G6 requires daily Perform a finger blood needle calibration).
Verily and Dexcom collaborate to create non-invasive CGM
Similarly, Google has invested in Oscar health multiple times, and it is Oscar health that is a third-party platform that can directly reach patients. Other third parties can build on it friendly. From an insurance company's point of view, Oscar has the potential to do this by allowing third parties to access their claims management + aggregated patient data, making it possible to distribute verily products and services. For example, Verily's product Onduo.
We're Professional Supplier Extract Powder manufacturers and suppliers in China specialized in providing high-quality products at low price. We warmly welcome you to buy or wholesale bulk Supplier Extract Powder for sale here from our factory. For a free sample, contact us now.
Supplier Extract Powder,Supplier Extract ,Supplier Powder Manufacturer in China
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com